<p>不幸的是，对于一些股东来说，<strong>Canopy Growth Corporation</strong>（多伦多证券交易所代码：WEED）的股价在过去三十天内下跌了 28%，延续了近期的痛苦。这一近期的下跌使得股东们在过去一年中遭遇了灾难性的表现，期间损失达 87%。</p>
<p>尽管其股价大幅下跌，但你仍然可以对 Canopy Growth 的市销率（P/S）为 0.8 倍感到无所谓，因为加拿大制药行业的中位市销率也接近 0.7 倍。不过，简单忽视市销率并不明智，因为投资者可能会忽略一个明显的机会或一个代价高昂的错误。</p>
<p>特朗普承诺要 “释放” 美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
<p>查看我们对 Canopy Growth 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/253665025-ps-multiple-vs-industry-1-dark/1743618329654?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/253665025-ps-multiple-vs-industry-1-dark/1743618329654"/></p>
<p>TSX:WEED 市销率与行业比较 2025 年 4 月 2 日</p>
<h3>Canopy Growth 最近的表现如何？</h3>
<p>Canopy Growth 最近的表现不佳，其收入下降与其他公司相比显得尤为糟糕，后者的收入平均有所增长。许多人可能期待收入表现的低迷会有所改善，这使得市销率没有下跌。然而，如果情况并非如此，投资者可能会因支付过高的股价而受到损失。</p>
<p>想了解分析师对公司的完整预测吗？那么我们 <strong>免费的</strong>Canopy Growth 报告将帮助你揭示未来的趋势。</p>
<h2>收入预测与市销率是否匹配？</h2>
<p>你唯一会对 Canopy Growth 这样的市销率感到满意的时机是当公司的增长与行业紧密相连时。</p>
<p>首先回顾一下，去年公司的收入增长并不令人兴奋，出现了令人失望的 5.4% 的下降。这意味着在更长的时间内，其收入也出现了下滑，过去三年总收入下降了 50%。因此，可以公平地说，最近的收入增长对公司来说是不可取的。</p>
<p>展望未来，覆盖该公司的八位分析师的估计显示，未来三年收入应每年增长 7.1%。而行业预计每年将实现 7.3% 的增长，因此公司有望实现相当的收入结果。</p>
<p>考虑到这一点，Canopy Growth 的市销率与其行业同行紧密匹配是有道理的。显然，股东们愿意在公司保持低调的同时继续持有股票。</p>
<h2>Canopy Growth 的市销率对投资者意味着什么？</h2>
<p>Canopy Growth 急剧下跌的股价使其市销率回到了与行业其他公司相似的水平。虽然市销率不应成为你是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
<p>我们看到 Canopy Growth 维持了一个适当的市销率，因为其收入增长数据与行业其他公司相匹配。目前，股东们对市销率感到满意，因为他们相当有信心未来的收入不会带来任何意外。综合考虑，如果市销率和收入预测没有重大冲击，那么在不久的将来，股价很难出现强劲的波动。</p>
<p>你需要注意风险，例如 - <strong>Canopy Growth 有 3 个警告信号</strong>（其中 1 个无法忽视），我们认为你应该了解。</p>
<p>如果你对盈利的强大公司感兴趣，那么你会想查看这份 <strong>免费的</strong> 有趣公司名单，这些公司以低市盈率交易（但已证明它们能够增长盈利）。</p>
<p>如果你想交易 Canopy Growth，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让你可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用、无账户最低限额，以及低至 0.03% 的外汇转换费率，远远优于大多数经纪商提供的服务。</p>
<p>赞助内容</p>

<p>Canopy Growth Corporation（多伦多证券交易所代码：WEED）在过去一个月的股价下跌了 28%，导致股东在过去一年中损失了 87%。该公司的市销率（P/S）为 0.8 倍，接近制药行业的中位数 0.7 倍。尽管去年收入下降了 5.4%，并且在三年内总共下降了 50%，分析师预测未来三年年均收入将温和增长 7.1%。投资者似乎持谨慎乐观态度，但仍然存在风险，包括公司面临的三个警示信号</p>

<p>Unfortunately for some shareholders, the <strong>Canopy Growth Corporation</strong> (TSE:WEED) share price has dived 28% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twelve months for shareholders, who are sitting on a 87% loss during that time.</p>
<div class="lb-trans"><p>不幸的是，对于一些股东来说，<strong>Canopy Growth Corporation</strong>（多伦多证券交易所代码：WEED）的股价在过去三十天内下跌了 28%，延续了近期的痛苦。这一近期的下跌使得股东们在过去一年中遭遇了灾难性的表现，期间损失达 87%。</p>
</div><p>Although its price has dipped substantially, you could still be forgiven for feeling indifferent about Canopy Growth's P/S ratio of 0.8x, since the median price-to-sales (or &#34;P/S&#34;) ratio for the Pharmaceuticals industry in Canada is also close to 0.7x. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.</p>
<div class="lb-trans"><p>尽管其股价大幅下跌，但你仍然可以对 Canopy Growth 的市销率（P/S）为 0.8 倍感到无所谓，因为加拿大制药行业的中位市销率也接近 0.7 倍。不过，简单忽视市销率并不明智，因为投资者可能会忽略一个明显的机会或一个代价高昂的错误。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承诺要 “释放” 美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
</div><p>See our latest analysis for Canopy Growth</p>
<div class="lb-trans"><p>查看我们对 Canopy Growth 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/253665025-ps-multiple-vs-industry-1-dark/1743618329654" alt="" original-src="https://images.simplywall.st/asset/chart/253665025-ps-multiple-vs-industry-1-dark/1743618329654"/></p>
<p>TSX:WEED Price to Sales Ratio vs Industry April 2nd 2025</p>
<div class="lb-trans"><p>TSX:WEED 市销率与行业比较 2025 年 4 月 2 日</p>
</div><h3>What Does Canopy Growth's Recent Performance Look Like?</h3>
<div class="lb-trans"><h3>Canopy Growth 最近的表现如何？</h3>
</div><p>Canopy Growth hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. It might be that many expect the dour revenue performance to strengthen positively, which has kept the P/S from falling. However, if this isn't the case, investors might get caught out paying too much for the stock.</p>
<div class="lb-trans"><p>Canopy Growth 最近的表现不佳，其收入下降与其他公司相比显得尤为糟糕，后者的收入平均有所增长。许多人可能期待收入表现的低迷会有所改善，这使得市销率没有下跌。然而，如果情况并非如此，投资者可能会因支付过高的股价而受到损失。</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on Canopy Growth will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想了解分析师对公司的完整预测吗？那么我们 <strong>免费的</strong>Canopy Growth 报告将帮助你揭示未来的趋势。</p>
</div><h2>Do Revenue Forecasts Match The P/S Ratio?</h2>
<div class="lb-trans"><h2>收入预测与市销率是否匹配？</h2>
</div><p>The only time you'd be comfortable seeing a P/S like Canopy Growth's is when the company's growth is tracking the industry closely.</p>
<div class="lb-trans"><p>你唯一会对 Canopy Growth 这样的市销率感到满意的时机是当公司的增长与行业紧密相连时。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 5.4%. This means it has also seen a slide in revenue over the longer-term as revenue is down 50% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.</p>
<div class="lb-trans"><p>首先回顾一下，去年公司的收入增长并不令人兴奋，出现了令人失望的 5.4% 的下降。这意味着在更长的时间内，其收入也出现了下滑，过去三年总收入下降了 50%。因此，可以公平地说，最近的收入增长对公司来说是不可取的。</p>
</div><p>Shifting to the future, estimates from the eight analysts covering the company suggest revenue should grow by 7.1% per year over the next three years. With the industry predicted to deliver 7.3% growth each year, the company is positioned for a comparable revenue result.</p>
<div class="lb-trans"><p>展望未来，覆盖该公司的八位分析师的估计显示，未来三年收入应每年增长 7.1%。而行业预计每年将实现 7.3% 的增长，因此公司有望实现相当的收入结果。</p>
</div><p>With this in mind, it makes sense that Canopy Growth's P/S is closely matching its industry peers. Apparently shareholders are comfortable to simply hold on while the company is keeping a low profile.</p>
<div class="lb-trans"><p>考虑到这一点，Canopy Growth 的市销率与其行业同行紧密匹配是有道理的。显然，股东们愿意在公司保持低调的同时继续持有股票。</p>
</div><h2>What Does Canopy Growth's P/S Mean For Investors?</h2>
<div class="lb-trans"><h2>Canopy Growth 的市销率对投资者意味着什么？</h2>
</div><p>Canopy Growth's plummeting stock price has brought its P/S back to a similar region as the rest of the industry. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.</p>
<div class="lb-trans"><p>Canopy Growth 急剧下跌的股价使其市销率回到了与行业其他公司相似的水平。虽然市销率不应成为你是否购买股票的决定性因素，但它是收入预期的一个相当有效的晴雨表。</p>
</div><p>We've seen that Canopy Growth maintains an adequate P/S seeing as its revenue growth figures match the rest of the industry. Right now shareholders are comfortable with the P/S as they are quite confident future revenue won't throw up any surprises. All things considered, if the P/S and revenue estimates contain no major shocks, then it's hard to see the share price moving strongly in either direction in the near future.</p>
<div class="lb-trans"><p>我们看到 Canopy Growth 维持了一个适当的市销率，因为其收入增长数据与行业其他公司相匹配。目前，股东们对市销率感到满意，因为他们相当有信心未来的收入不会带来任何意外。综合考虑，如果市销率和收入预测没有重大冲击，那么在不久的将来，股价很难出现强劲的波动。</p>
</div><p>You need to take note of risks, for example - <strong>Canopy Growth has 3 warning signs</strong> (and 1 which can't be ignored) we think you should know about.</p>
<div class="lb-trans"><p>你需要注意风险，例如 - <strong>Canopy Growth 有 3 个警告信号</strong>（其中 1 个无法忽视），我们认为你应该了解。</p>
</div><p>If strong companies turning a profit tickle your fancy, then you'll want to check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>如果你对盈利的强大公司感兴趣，那么你会想查看这份 <strong>免费的</strong> 有趣公司名单，这些公司以低市盈率交易（但已证明它们能够增长盈利）。</p>
</div><p>If you're looking to trade Canopy Growth, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果你想交易 Canopy Growth，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让你可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用、无账户最低限额，以及低至 0.03% 的外汇转换费率，远远优于大多数经纪商提供的服务。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

Canopy Growth Corporation (TSE:WEED) 股价暴跌 28% 后，你能从其市销率中学到什么？